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Background: Video capsule endoscopy (VCE) is mainly used to evaluate patients with celiac disease in whom their
course after diagnosis has been unfavorable and the diagnosis of adenocarcinoma, lymphoma or refractory celiac
disease is entertained, but it has been suggested that VCE could replace esophagogastroduodenoscopy (EGD) and
biopsy under certain circumstances.
Methods: We report a single center case series of 8 patients with suspected celiac disease who were diagnosed by
VCE.
Results: EGD and biopsy had been performed in 4 patients resulting in a negative biopsy, declined by 2, and
contraindicated in 2 due to hemophilia and von Willebrand disease. In all patients, mucosal changes of scalloping,
mucosal mosaicism and reduced folds were seen in either the duodenum or jejunum on VCE. Follow-up in 7
patients demonstrated improvement in either their serological abnormalities or their presenting clinical features on
a gluten-free diet.
Conclusions: Our case series demonstrates that VCE and the visualization of the characteristic mucosal changes of
villous atrophy may replace biopsy as the mode of diagnosis when EGD is either declined or contraindicated, or
when duodenal biopsies are negative and there remains a high index of suspicion. Further study is needed to
clarify the role and cost of diagnosing celiac disease with VCE.
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Esophagogastroduodenoscopy (EGD) with duodenal bi-
opsy is considered the gold standard for the diagnosis of
celiac disease. However, the histological lesions charac-
teristic for celiac disease may be missed in cases of
patchy duodenal atrophy, even with multiple duodenal
biopsies [1,2]. Despite this approach, some patients with
a clinical presentation that is highly suggestive for celiac
disease may still have a normal appearing EGD and non-
diagnostic biopsy. These patients are usually not placed* Correspondence: pg11@columbia.edu
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reproduction in any medium, provided the oron a gluten-free diet because of the lack of pathological
confirmation of villous atrophy. In addition some
patients may not be candidates for EGD because of rela-
tive medical contraindications, such as from a bleeding
diathesis, or fear of the procedure.
Video capsule endoscopy (VCE) provides high-
resolution magnified views of the small intestinal mu-
cosa in a noninvasive manner and has been shown to be
sensitive (76–99%) and specific (56–100%) for identify-
ing celiac disease [3]. Some features that can be
observed with VCE include reduced duodenal folds; scal-
loping, layering, or stacking of folds; mucosal fissures,
crevices, grooves, nodularity or a mosaic pattern [4].
Currently, VCE is mainly used to evaluate patients with
celiac disease in whom their course after diagnosis hasLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Chang et al. BMC Gastroenterology 2012, 12:90 Page 2 of 5
http://www.biomedcentral.com/1471-230X/12/90been unfavorable and the diagnosis of adenocarcinoma,
lymphoma or refractory celiac disease is entertained [5].
VCE allows visualization of the entire small bowel, po-
tentially locating more distal and patchy disease that
may be missed by EGD [6]. Because of the high specifi-
city for the presence of villous atrophy when the appro-
priate mucosal abnormalities are visualized, it has been
proposed that VCE may replace EGD with biopsy in
selected circumstances [5]. These include patients in
whom there is a high clinical suspicion (supportive his-
tory, positive serologies), but a normal EGD and unre-
markable biopsy and in those patients with bleeding
diatheses and severe cardiopulmonary disease, or who
decline EGD [5]. There has, however, been no literature
supporting this approach. We therefore report a case
series confirming the appropriateness of this method.
Methods
Patients
This was a retrospective review of eight patients seen at
the Celiac Disease Center at Columbia University Med-
ical Center (CUMC) for an evaluation of possible celiac
disease. The Celiac Disease Center is a tertiary referral
center that has a cohort of 1,285 patients with celiac dis-
ease. Patients that were included in our evaluation had
both: 1) suspected celiac disease and 2) either a normal
EGD with a non-diagnostic biopsy, or were unable to
undergo EGD with biopsy, either because of medical co-
morbidities or personal preference.
Patients were considered to have suspected celiac dis-
ease if their clinical presentation included the presence
of at least one of the following: abdominal pain, chronic
diarrhea, unexplained anemia, osteoporosis, unexplained
neuropathy, and/or unexplained weight loss. Patients
also had a positive serologic test, preferably either a
positive anti-endomysial antibody (EMA) or anti-tissue
transglutaminase (tTG) antibody. Patients were not on aTable 1 Characteristics of patients who were diagnosed with






1 F/29 Osteoporosis None* +EM
2 F/65 Peripheral neuropathy None* +AG
3 F/20 Iron deficiency anemia Sister Nega
4 M/64 Diarrhea None* Nega
5 M/45 Diarrhea None +AG
6 M/58 Diarrhea None +EM
7 M/19 Screening for celiac disease
due to family history
Father +EM
8 F/16 Iron deficiency anemia None† +EM
Abbreviations: anti-endomysial antibody (EMA), anti-gliadin antibody (AGA), anti-tis
Immunoglobulins measured for AGA and TTG were IgG and IgA, respectively.
HLA typing when performed were denoted by * for DQ2 positive and † for DQ8 pogluten-free diet at the time of evaluation. A normal EGD
and non-diagnostic biopsy was defined as having a
Marsh score of 0. Patients that were unable to undergo
biopsy for medical reasons primarily included patients at
risk of excessive bleeding. Patients that declined EGD
were also included. This study was reviewed and
approved by the CUMC Institutional Review Board.Procedures
Patients underwent EGD at the CUMC Endoscopy Unit.
At least 4–8 duodenal biopsies were performed as part
of standard clinical care. Specimens were interpreted by
a staff gastrointestinal pathologist. VCE was performed
using the Given PillCamSB (Given Imaging, Yoqneam,
Israel). VCE findings were considered as consistent with
celiac disease if at least one of the following was present:
reduced duodenal folds; scalloping, or reduction of folds;
mucosal fissures, crevices, grooves, or a mosaic pattern
[4]. VCE images were interpreted by gastroenterologists
experienced in VCE. Localization within the small bowel
was approximated using anatomic landmarks (major am-
pulla) for the duodenum and dividing the duration of
the small bowel transit into two parts for the jejunum
and ileum.Results
Eight patients were found to fulfill the criteria for sus-
pected celiac disease and had undergone VCE confirm-
ing celiac disease (Table 1). Half were female with a
median age of 25 (range 16–65 years). Patients under-
went evaluation for celiac disease because of gastrointes-
tinal complaints and diarrhea (n = 3), iron deficiency
anemia (n = 2), osteoporosis (n = 1), neuropathy (n = 1),
and for screening in the setting of a family history of ce-
liac disease (n = 1). Six patients (75%) had serologic test-








A Declined Not performed
A, TTG Declined Not performed
A, TTG Not performed Contraindicated - Hemophilia
A, TTG Not performed Contraindicated - Von Willebrand disease
sue transglutaminase antibody (TTG).
sitive.
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patients had a first-degree relative with celiac disease.
Four patients (50%) had a normal EGD and Marsh
stage 0 biopsy. The other four patients never underwent
EGD, of which two patients (patients 7 and 8) had a
bleeding diathesis (von Willebrand disease and
hemophilia) and two patients (patients 5 and 6) declined.
Patient 5 reported a prior diagnosis of celiac disease as a
child and did not have any records to confirm this, but
preferred not to undergo EGD. Patient 6 declined EGD
because of concerns regarding the potential associated
complications. Mucosal changes suggestive of villous at-
rophy were seen in all patients by VCE in either the
duodenum or jejunum, including scalloping, absent
folds, or mucosal mosaicism (Figure 1). Mucosal ero-
sions were identified in 4 patients. The capsule did not
cross the ileocecal valve in patient 2, but a follow-up
radiograph did not show a retained capsule and there
were no complications from VCE.
All patients were seen by a trained dietitian and com-
menced a gluten-free diet; seven patients (88%) demon-
strated improvement in either their serologicalFigure 1 Video capsule endoscopy images found in celiac disease acc
Villous atrophy (absent villi) and mild scalloping, Patient 3. Absent and redu
jejunal villi, Patient 6. Mosaic, cobblestoned pattern with marked scallopingabnormalities or their presenting clinical features on a
gluten-free diet. Patients 4, 5, and 6 had improvement in
diarrhea, patients 3 and 8 had improvements in anemia,
and patient 1 had an improvement in her DEXA scan.
This improvement was particularly dramatic for patient
3 who, prior to a gluten-free diet, had required transfu-
sions and had been on both iron supplementation and
oral contraceptives to control her menses. Patient 2 did
not have any improvement in her neuropathy and
gastrointestinal symptoms after 15 months on a gluten-
free diet and was subsequently lost to follow up.
Discussion
Our study demonstrates that VCE can be used to diag-
nose celiac disease in patients with suspected celiac dis-
ease who have either a non-diagnostic EGD with biopsy
or who are unable or unwilling to undergo EGD. Al-
though VCE is used to diagnose celiac disease in clinical
practice, previous guidelines have not recommended this
approach and our study is the first to support its role in
diagnosing celiac disease. It is unclear what proportion
of patients that have positive celiac disease serologies,ording to patient. Patient 1. Villous atrophy (absent villi), Patient 2.
ced villi. Patient 4, Scalloping, crevices, atrophy, Patient 5. Absent
of folds, Patient 7. Crevices, atrophy, scalloping, Patient 8. Scalloping.
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having latent celiac disease and are usually not advised
to commence a gluten-free diet), will have a VCE that is
diagnostic for celiac disease. One small series did not
find celiac disease in this situation [7], but there is grow-
ing evidence that celiac disease may sometimes vary in
distribution, appearing more distally and patchy in na-
ture [6,8]. However, before embarking on additional test-
ing with VCE, it is important to first confirm the
adequacy of the initial diagnostic work up, starting from
a meticulous endoscopic evaluation, to taking a suffi-
cient number biopsies, and finally having an experienced
gastrointestinal pathologist interpret the pathology. Add-
itionally, a trial of a gluten-free diet as a diagnostic
method should be avoided as it can negatively impact
quality of life, is difficult to adhere to, and overall more
expensive, particularly in the United States where there
is limited availability of gluten-free foods.
Traditionally celiac disease is diagnosed by biopsy of
the duodenum in individuals with positive serological
tests. Negative biopsies in this setting result in a consid-
eration that the serological tests were false positives, or
the patient has potential or latent celiac disease. This re-
sult could however be the result of either an inadequate
number of biopsies [2] or that the duodenal bulb was
not biopsied [9]. Our results would suggest that when
the index of suspicion is high, VCE may confirm the
diagnosis of celiac disease in this setting. This is based
on the high specificity for the mucosal abnormalities
associated with the presence of villous atrophy. However,
a negative VCE in which the characteristic endoscopic
appearance of villous atrophy is not appreciated does
not exclude celiac disease, as villous atrophy may be
present in the setting of a normal endoscopic appear-
ance (low sensitivity).
Our findings were limited by our small cohort size
and retrospective study design. Ideally we would have
also confirmed mucosal recovery in addition to symp-
tomatic and laboratory improvement with a repeat VCE
while on a gluten-free diet. Although we were unable
to obtain a tissue diagnosis of celiac disease in our
series, the vast majority of the patients developed clin-
ical improvement after starting a gluten-free diet, which
was able to confirm the diagnosis of celiac disease.
Patients with suspected celiac disease that do not im-
prove on a gluten-free diet should be followed closely
by a nutritionist experienced with celiac disease, and
may possibly benefit from a repeat VCE with or with-
out a gluten challenge.
Conclusion
In our selected series of patients the presence of villous
atrophy was confirmed by the VCE appearance of the
duodenal or jejunal mucosa. While the sensitivity ofdiagnosing celiac disease by VCE in the presence of se-
vere degrees of villous atrophy appears high [8], it
remains to be seen whether newly developed computer-
ized image analysis techniques can facilitate the detec-
tion of lesser degrees of villous atrophy [10]. Larger,
controlled trials are needed to confirm the accuracy of
VCE as compared to EGD with biopsy in diagnosing, ra-
ther than monitoring, celiac disease. Further studies doc-
umenting the cost effectiveness of VCE as compared to
EGD, and patient preference studies, need to be
performed.
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